Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 7/20 | 0.54 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.54 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.51 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.51 |
| ▸ | CD69 | Q07108 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7153589 | 1.00 | LGALS3 (0.54) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB | |
| SCHEMBL29305312 | 1.00 | LGALS3 (0.54) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB | |
| SCHEMBL16476748 | 1.00 | LGALS3 (0.54) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB | |
| SCHEMBL7153592 | 1.00 | LGALS3 (0.54) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB | |
| SCHEMBL17953133 | 0.95 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB | |
| SCHEMBL13136604 | 0.95 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB | |
| SCHEMBL15386146 | 0.95 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB | |
| SCHEMBL16675413 | 0.95 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB | |
| SCHEMBL10023255 | 0.95 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB | |
| SCHEMBL13799095 | 0.95 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140107015-A1 | PHARAMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HUMAN IMMUNODEFICIENCY VIRUS | PUKYONG NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2014-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140107015-A1 | PHARAMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HUMAN IMMUNODEFICIENCY VIRUS | PEPD, CD4, DNPEP | LGALS3 396/4885LGALS7; LGALS7B 670/4885LGALS1 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.